Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-23-010643

CFO acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Burns John Thomas CFO 2023-02-02 Grant or award +20,000 49,347 D
Derivatives
Burns John Thomas CFO 2023-02-02 Grant or award · Stock Option Right to Buy) +75,000 75,000 D
Loading xslF345X03/tm235353d8_4seq1.xml…